StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.00 (0.00%)

Close on Nov 17, 2026Market cap $25.06MP/E –Yield –

ABVC BioPharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

ABVC BioPharma's operating income for the twelve months ending Jun 30, 2026 was -$6.52M. For fiscal 2025 it was -$7.15M. The highest annual figure on record is -$177.26K in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.15M–
FY2024Dec 31, 2024-$4.71M–
FY2023Dec 31, 2023-$6.77M–
FY2022Dec 31, 2022-$15.11M–
FY2021Dec 31, 2021-$11.71M–
FY2020Dec 31, 2020-$8.51M–
FY2019Dec 31, 2019-$3.46M–
FY2017Sep 30, 2017-$4.00M–
FY2016Sep 30, 2016-$11.00M–
FY2013Sep 30, 2013-$177.26K–
FY2012Sep 30, 2012-$1.14M–
FY2011Sep 30, 2011-$1.89M–
FY2010Sep 30, 2010-$1.89M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$779.53K–
Q1 FY2026CQ1 2026Mar 31, 2026-$1.57M–
Q4 FY2025CQ4 2025Dec 31, 2025-$2.20M–
Q3 FY2025CQ3 2025Sep 30, 2025-$1.96M–
Q2 FY2025CQ2 2025Jun 30, 2025-$2.29M–
Q1 FY2025CQ1 2025Mar 31, 2025-$693.01K–
Q4 FY2024CQ4 2024Dec 31, 2024-$704.56K–
Q3 FY2024CQ3 2024Sep 30, 2024-$302.32K–
Q2 FY2024CQ2 2024Jun 30, 2024-$860.11K–
Q1 FY2024CQ1 2024Mar 31, 2024-$2.84M–
Q4 FY2023CQ4 2023Dec 31, 2023-$511.84K–
Q3 FY2023CQ3 2023Sep 30, 2023-$2.15M–
Q2 FY2023CQ2 2023Jun 30, 2023-$2.19M–
Q1 FY2023CQ1 2023Mar 31, 2023-$1.91M–
Q4 FY2022CQ4 2022Dec 31, 2022-$3.13M–
Q3 FY2022CQ3 2022Sep 30, 2022-$3.72M–
Q2 FY2022CQ2 2022Jun 30, 2022-$2.05M–
Q1 FY2022CQ1 2022Mar 31, 2022-$6.22M–
Q4 FY2021CQ4 2021Dec 31, 2021-$6.45M–
Q3 FY2021CQ3 2021Sep 30, 2021-$1.97M–
Q2 FY2021CQ2 2021Jun 30, 2021-$2.04M–
Q1 FY2021CQ1 2021Mar 31, 2021-$1.25M–
Q4 FY2020CQ4 2020Dec 31, 2020-$4.85M–
Q3 FY2020CQ3 2020Sep 30, 2020-$1.29M–
Q2 FY2020CQ2 2020Jun 30, 2020-$1.19M–
Q1 FY2020CQ1 2020Mar 31, 2020-$1.17M–
Q4 FY2019CQ4 2019Dec 31, 2019-$1.12M–
Q3 FY2019CQ3 2019Sep 30, 2019-$1.12M–
Q2 FY2019CQ2 2019Jun 30, 2019-$488.81K–
Q1 FY2019CQ1 2019Mar 31, 2019-$730.57K–
Q4 FY2017CQ3 2017Sep 30, 2017-$3.36M–
Q3 FY2017CQ2 2017Jun 30, 2017-$189.48K–
Q2 FY2017CQ1 2017Mar 31, 2017-$236.84K–
Q1 FY2017CQ4 2016Dec 31, 2016-$210.39K–
Q4 FY2016CQ3 2016Sep 30, 2016-$647.78K–
Q3 FY2016CQ2 2016Jun 30, 2016-$289.10K–
Q2 FY2016CQ1 2016Mar 31, 2016-$6.61M–
Q1 FY2016CQ4 2015Dec 31, 2015-$3.50M–
Q3 FY2015CQ2 2015Jun 30, 2015-$1.50K–

More ABVC BioPharma figures

See a number that looks wrong?